Abdul Abdellatif is a Nephrology physician affiliated with Baylor College of Medicine. OpenAlex indexes 47 publications with 538 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Kobayashi Ste 311
Webster, TX 775984841
Telephone
281-724-8296Provider last certified this registry record 2 Jun 2026.
Industry payments
45 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year202563 payments$71,040openpaymentsdata.cms.gov ↗
- Travere Therapeutics, Inc.Program year202592 payments$47,664openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202541 payments$29,832openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
82%Other drugs affecting bone structure and mineralization45.2%Romosozumab-aqqg100%Part B, office-administered≥12 patientsRANK Ligand Inhibitor35.4%Denosumab100%Part B, office-administered≥94 patients+ 7 more classes in this area
Cardiovascular
8.1%Beta blocker1.6%Carvedilol58%Metoprolol Tartrate18%Metoprolol Succinate8%Propranolol Hcl6%Labetalol Hcl4%Atenolol4%Bisoprolol-Hydrochlorothiazide3%Part D<11 patientsCalcium channel blocker1.3%Amlodipine Besylate53%Nifedipine Er35%Diltiazem 12hr Er5%Diltiazem 24hr Er (Cd)4%Diltiazem Hcl4%Part D<11 patients+ 16 more classes in this area
Metabolism & gastrointestinal
4%Proton pump inhibitor0.8%Pantoprazole Sodium71%Omeprazole29%Part D≥41 patientsVitamin D3 Analog0.6%Calcitriol81%Rayaldee19%Part D<11 patients+ 15 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dual-Energy CT Bone Erosion Findings Before and After Pegloticase Treatment in Kidney Transplant Patients with Uncontrolled Gout: PROTECT Trial
American Journal of Transplantation
2025 - Kidney Safety Findings in Patients with Uncontrolled Gout Treated with Pegloticase with and Without Methotrexate
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
Malcolm Brenner, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”